NOTICE OF INTENT TO SOLE SOURCE - Chronic Kidney Disease Epidemiology in the Military Health System
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC) intends to award a Firm-Fixed-Price sole source contract to the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) for Chronic Kidney Disease (CKD) Epidemiology in the Military Health System (MHS). This is a Notice of Intent to Sole Source, not a request for competitive proposals. However, capability statements from other responsible sources will be considered if received by June 18, 2026.
Purpose & Scope of Work
The contract aims to provide continued support for CDC’s CKD surveillance and epidemiology activities. HJF will facilitate access to and analysis of MHS data to establish and maintain an analytical database. This database will be used to assess the epidemiology of CKD diagnosis, treatment, complications, and outcomes within the MHS. Key activities include epidemiologic analyses of CKD and end-stage kidney disease (ESKD), assessment of risk factors, evaluation of disease patterns among active-duty and non-active-duty populations, characterization of pediatric CKD, and investigation of rare causes of CKD.
Contract Details
- Contract Type: Firm-Fixed-Price, Sole Source
- Awardee: Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF)
- Justification: FAR 6.302-1, Only One Responsible Source. HJF is identified as the only known source with the necessary access, resources, and capabilities to meet the requirement without disruption, and award to another source would result in substantial duplication of cost and unacceptable delays.
- Period of Performance: June 14, 2026, through June 13, 2030, consisting of a one-year base period and three one-year option periods.
- Agency: Department of Health and Human Services, Centers for Disease Control and Prevention
- Place of Performance: Bethesda, MD 20817, United States
- Set-Aside: Not Applicable (Sole Source)
Response Information
This notice is not a request for competitive proposals. However, all capability statements, proposals, or quotations received within fifteen (15) calendar days after publication of this notice (by June 18, 2026) shall be considered by the Government. The decision to conduct a competitive procurement based on responses is solely at the Government's discretion. Information received will primarily be used to determine if a competitive procurement is feasible.
Contact Information
- Contract Specialist: Ann Bonis
- Email: won5@cdc.gov